Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Endoscopic Suturing (ES) Registry

6. desember 2021 oppdatert av: American Gastroenterological Association

Prospective Registry for Trans-Orifice Endoscopic Suturing Applications

To determine patient outcomes (survival, additional endoscopic or surgical procedures) with an endoscopic suturing technique at predetermined intervals compared to historical controls when applicable.

To evaluate the efficacy, safety, and durability of trans-orifice endoscopic suturing therapy for revision of bariatric procedures as well as study the safety, efficacy, and durability of preventative fixation of GI endoprosthetics.

Studieoversikt

Status

Fullført

Forhold

Detaljert beskrivelse

To determine patient outcomes (survival, morbidity including hospitalization, additional re-interventions with radiologic, endoscopic or surgical procedures) with endoscopic suturing at predetermined intervals from the last endoscopic suturing procedure or at failure of the endoscopic suturing with conversion to another intervention such as surgery and compared to historical controls when applicable.

To evaluate the efficacy and safety of endoscopic suturing therapy in preventative fixation of stents and bariatric revision.

To collect data on the common use endoscopic suturing therapy in other indications.

This prospective clinical study is a real-world registry and not a randomized controlled trial. Given the conditions commonly treated with endoscopic suturing and the potential lack of equivalent expertise in open, laparoscopic, and trans-oral surgical procedures at all centers, randomization of participants is not possible nor ethical. In addition, there are clinical scenarios where endoscopic therapy with surgical sutures, tissue sealants, and/or endoprosthetics may be appropriate and open and laparoscopic surgical approaches inappropriate from an ethical viewpoint. Given the multitude of currently available minimally invasive approaches to repair, it would be unethical to expose and randomize patients who are suitable for more minimally invasive approaches to a more invasive and inherently more morbid approach.

This outcomes study is external to the subject receiving the medical device treatment. Subjects will receive the medical device treatment regardless of study participation and the surgery is not part of this research. Subjects will be consented prior to their procedure, to obtain basic follow-up information. If the subject provides informed consent to participate in the registry, then site staff will follow the participant's clinical data for the period of the registry. Site staff may also contact the subject(s) during their standard clinic visit or via the telephone and obtain information on: overall health, specific events related to any subsequent surgical, endoscopic, or radiologic interventions, and hospitalizations.

The clinical data will be collected during usual procedure follow-ups. This will include recording patient demographics, medications, testing results, comorbidities, body mass index, and reason for clinical care visit. If during the follow-up period, the subject undergoes additional clinically indicated procedures or hospitalizations for procedure related indications then the site will submit this information to the registry.

All procedures and device use will be performed as clinically indicated and as directed by the treating physician. All information requested as part of this registry will be obtained from clinical data obtained as part of study.

Studietype

Observasjonsmessig

Registrering (Faktiske)

204

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Arkansas
      • Little Rock, Arkansas, Forente stater, 72211
        • University of Arkansas
    • Florida
      • Jacksonville, Florida, Forente stater, 32224
        • Mayo Clinic Jacksonville
      • Jacksonville, Florida, Forente stater, 32256
        • Borland Grover Clinic
    • Illinois
      • Evanston, Illinois, Forente stater, 60201
        • NorthShore University HealthSystem
    • Maryland
      • Baltimore, Maryland, Forente stater, 21224
        • Johns Hopkins Medical Institution
    • Missouri
      • Saint Louis, Missouri, Forente stater, 63110
        • Washington University
    • New York
      • Manhasset, New York, Forente stater, 11030
        • Northwell Health
      • New York, New York, Forente stater, 10021
        • New York Presbyterian Hospital
      • New York, New York, Forente stater, 10029
        • Mount Sinai Hospital
    • Pennsylvania
      • Hershey, Pennsylvania, Forente stater, 17033
        • Penn State Hershey Medical Center
    • Texas
      • Dallas, Texas, Forente stater, 75214
        • Methodist Dallas Medical Center

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

N/A

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Adults with a condition that can be treated with trans-orifice endoscopic surgery.

Beskrivelse

Inclusion Criteria:

  1. Selected to undergo trans-orifice suturing prior to study enrollment
  2. Age 18+ years
  3. Patient ASA classification I, II, III, including emergency cases
  4. Patient willing to provide informed consent, cooperate with post-operative recommendations and follow-up assessment

Exclusion Criteria:

  1. Patients who do not meet the clinical criteria for trans-orifice suturing
  2. Under age 18 years
  3. ASA classification IV
  4. Unable to provide informed consent
  5. Unable to participate in follow-up assessments
  6. Uncorrectable coagulopathy at the time of endoscopic suturing
  7. Any terminal disease that limits patient's survival to less than one year

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
no groups - observational study

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Dislocation of Stent - distance
Tidsramme: Change at 2 weeks, 30 days, 3 months
Change in the position measured using distance (centimeters).
Change at 2 weeks, 30 days, 3 months
Dislocation of Stent - location
Tidsramme: Change at 2 weeks, 30 days, 3 months
Change in the position measured using location. Location options: Bridging the GJ anastomosis, Confined to gastric lumen, Bridging the pylorus, Bridging Lower Esophageal Sphincter
Change at 2 weeks, 30 days, 3 months
Migration Rate of Stent - placement
Tidsramme: Change at 2 weeks, 30 days, 3 months
Distal from placement over time (yes or no)
Change at 2 weeks, 30 days, 3 months
Migration Rate of Stent - replaced
Tidsramme: Change at 2 weeks, 30 days, 3 months
Stent replaced or re-structured over time (yes or no)
Change at 2 weeks, 30 days, 3 months
Migration Rate of Stent - sutures
Tidsramme: Change at 2 weeks, 30 days, 3 months
Number of intact Sutures
Change at 2 weeks, 30 days, 3 months
Migration Rate of Stent - removal
Tidsramme: Change at 2 weeks, 30 days, 3 months
Days to removal and replacement
Change at 2 weeks, 30 days, 3 months
Excess Weight Loss
Tidsramme: Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
Changes in body weight measured in kilograms subsequent to the revisional procedure will be summarized using statistics both in percentage terms using the % excess weight lost and absolute terms.
Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
Total Weight Loss
Tidsramme: Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
Changes in body weight measured in kilograms subsequent to the revisional procedure will be summarized using statistics both in percentage terms using the % total weight loss and absolute terms.
Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Samarbeidspartnere

Etterforskere

  • Hovedetterforsker: Jennifer Maranki, MD, Penn State Milton S. Hershey School of Medicine

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

29. oktober 2018

Primær fullføring (Faktiske)

30. november 2021

Studiet fullført (Faktiske)

30. november 2021

Datoer for studieregistrering

Først innsendt

3. november 2018

Først innsendt som oppfylte QC-kriteriene

13. desember 2018

Først lagt ut (Faktiske)

14. desember 2018

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

7. desember 2021

Siste oppdatering sendt inn som oppfylte QC-kriteriene

6. desember 2021

Sist bekreftet

1. desember 2021

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • ES Registry 2-682-101

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Kirurgi

3
Abonnere